Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$35.55 - $43.57 $127,695 - $156,503
3,592 Added 5.95%
63,923 $2.78 Million
Q3 2023

Nov 13, 2023

SELL
$39.13 - $47.24 $133,198 - $160,804
-3,404 Reduced 5.34%
60,331 $2.44 Million
Q2 2023

Aug 15, 2023

BUY
$43.93 - $46.76 $212,577 - $226,271
4,839 Added 8.22%
63,735 $2.87 Million
Q1 2023

May 12, 2023

BUY
$45.29 - $50.76 $465,988 - $522,269
10,289 Added 21.17%
58,896 $2.71 Million
Q4 2022

Feb 13, 2023

BUY
$41.91 - $50.48 $200,832 - $241,900
4,792 Added 10.94%
48,607 $2.42 Million
Q3 2022

Nov 14, 2022

SELL
$40.9 - $50.42 $886,712 - $1.09 Million
-21,680 Reduced 33.1%
43,815 $1.81 Million
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $475,917 - $551,103
11,073 Added 20.35%
65,495 $3.09 Million
Q1 2022

May 16, 2022

BUY
$42.23 - $54.3 $459,462 - $590,784
10,880 Added 24.99%
54,422 $2.67 Million
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $27.2 Million - $30.4 Million
-538,192 Reduced 92.52%
43,542 $2.42 Million
Q3 2021

Nov 15, 2021

BUY
$46.55 - $56.83 $52,182 - $63,706
1,121 Added 0.19%
581,734 $30.1 Million
Q2 2021

Aug 16, 2021

BUY
$46.28 - $52.75 $242,784 - $276,726
5,246 Added 0.91%
580,613 $28.1 Million
Q1 2021

May 13, 2021

BUY
$46.25 - $56.02 $6.8 Million - $8.24 Million
147,105 Added 34.35%
575,367 $28 Million
Q4 2020

Feb 09, 2021

BUY
$46.09 - $54.74 $13.5 Million - $16 Million
292,071 Added 214.46%
428,262 $22.6 Million
Q3 2020

Nov 05, 2020

SELL
$42.51 - $52.42 $20,022 - $24,689
-471 Reduced 0.34%
136,191 $7.12 Million
Q2 2020

Aug 13, 2020

BUY
$39.49 - $44.36 $2.25 Million - $2.53 Million
57,023 Added 71.6%
136,662 $5.85 Million
Q1 2020

May 14, 2020

BUY
$33.17 - $41.6 $2.64 Million - $3.31 Million
79,639 New
79,639 $3.31 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.4B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.